Interactions between matrix hyaluronan (HA), the major glycosaminoglycan component of extracellular matrix (ECM), and variant isoforms of CD44 (HA receptor) have been shown to be tightly linked to the development of aberrant signaling events in a variety of cancers (4, 5, 5–30). The gene discussed is CD44; the disease is cancer.